Syther Peptides
REF · CJC-1295-IPAMORELIN · TIER B

CJC-1295 + Ipamorelin

(Research Blend)

A research blend of the GHRH analog CJC-1295 and the selective growth-hormone-secretagogue Ipamorelin.

Identity & Classification

Class
GHRH analog + GHS-R agonist pentapeptide
Research category
Somatotropic-Axis Research
Range
New / Branded
Risk tier
Tier B

Full identity reference: GHRH analog + GHS-R agonist pentapeptide. CAS each confirm from COA.

Mechanism Studied in Research

Pairs GHRH-receptor and ghrelin/GHS-receptor signalling in somatotropic-axis research models.

Research Interest Areas

GH-secretagogue pharmacology, dual-pathway receptor studies.

Specifications

Form
Lyophilised solid
Kit total
10mg
Vial config
5mg x 2
QC
HPLC / MS Certificate of Analysis
Lead time
Confirmed at quote
Supply basis
Research use only · institution-verified

Source: 10mg kit, 5mg/vial x 2, lyophilised. Purity by HPLC/MS COA.

Storage & Handling

Reference material is supplied lyophilised in sealed vials. Recommended laboratory handling: store sealed vials at -20°C protected from light and moisture. Once reconstituted in a research-grade aqueous buffer, hold at 2–8°C for short-term use or aliquot and store at -20°C or below to limit freeze-thaw cycles. Allow vials to equilibrate to room temperature before opening to prevent condensation.

Reconstitution buffer, concentration, and assay format are determined by the receiving laboratory’s protocol. Syther Peptides does not supply usage protocols.

Quality & Compliance

Manufacturing
WHO-GMP
API grade
USP / BP
Identity & purity
HPLC / MS
Per-vial
Scratch-code

Certificate of Analysis

Purity and identity are confirmed by Certificate of Analysis (HPLC / MS), available on request alongside the quote. The COA documents batch number, identity confirmation method, purity by HPLC peak-area, and reference to the analytical method used.

How to Enquire

  1. STEP / 01
    Submit enquiry

    Provide institution, intended laboratory application, compound, quantity and format.

  2. STEP / 02
    Research-gate check

    We confirm research-organisation context. Enquiries that cannot evidence one are declined.

  3. STEP / 03
    Quote & COA

    Availability, lead time, and Certificate of Analysis returned within one business day.

FAQ

What is the CJC-1295 + Ipamorelin blend?
It is a research-use-only co-formulation of a GHRH analog and a selective GH-secretagogue used in laboratory somatotropic-axis research. Not for human use.
What class of peptide is CJC-1295 + Ipamorelin?
CJC-1295 + Ipamorelin is described as: GHRH analog + GHS-R agonist pentapeptide.
What pathway or receptor does CJC-1295 + Ipamorelin act on?
Pairs GHRH-receptor and ghrelin/GHS-receptor signalling in somatotropic-axis research models.
What is CJC-1295 + Ipamorelin studied for in research?
Research interest areas include: GH-secretagogue pharmacology, dual-pathway receptor studies.
Is CJC-1295 + Ipamorelin for human use?
No. CJC-1295 + Ipamorelin is supplied for laboratory research use only and is not for human or veterinary consumption.
How is identity and purity of CJC-1295 + Ipamorelin confirmed?
Identity and purity are confirmed by HPLC/MS Certificate of Analysis, supplied on request. Every vial carries a scratch-code that can be verified on this site.
Identity & Classification

Reference Specification

ClassGHRH analog + GHS-R agonist pentapeptide
CategorySomatotropic-Axis Research
FormatLyophilised
Vial config5mg x 2
Risk TierTier B
HPLC/MS COA · WHO-GMP · Scratch-code
Enquiry

Enquire for availability. Responses within one business day.

Start enquiry

Related research compounds

For laboratory and research use only. Not for human or veterinary consumption. Not for diagnostic, therapeutic, or clinical use.